Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-18-006811
Filing Date
2018-05-24
Accepted
2018-05-24 08:00:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0518schreiber_immudyne.htm SC 13D 39665
  Complete submission text file 0001213900-18-006811.txt   40962
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Subject) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90483 | Film No.: 18856665
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 53 CALLE PALMERAS SUITE 802 SAN JUAN PR 00901
Business Address
Schreiber Justin (Filed by) CIK: 0001720512 (see all company filings)

Type: SC 13D